Bases bibliographiques Pascal et Francis

Aide

Export

Sélection :

Lien permanent
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22275367

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

Auteur
HUYNH, Hung1 ; VAN CHANH NGO1 ; BOON CHER GOH6 ; SMITH, Paul D7 ; KHEE CHEE SOO1 ; HENG NUNG KOONG2 ; POON, Donald3 ; SU PIN CHOO3 ; HAN CHONG TOH3 ; CHOON HUA THNG4 ; CHOW, Pierce5 ; HOCK SOO ONG5 ; CHUNG, Alexander5
[1] Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre, 11 Hospital Drive, Singapore 169610, Singapore
[2] Department of Surgical Oncology, National Cancer Centre, 11 Hospital Drive, Singapore 169610, Singapore
[3] Department of Medical Oncology, National Cancer Centre, 11 Hospital Drive, Singapore 169610, Singapore
[4] Department of Oncologic Imaging, National Cancer Centre, 11 Hospital Drive, Singapore 169610, Singapore
[5] Department of General Surgery, Singapore General Hospital, Outram Road, Singapore 169608, Singapore
[6] National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, Singapore
[7] Cancer and Infection, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK104TG, United Kingdom
Source

Journal of hepatology. 2010, Vol 52, Num 1, pp 79-87, 9 p ; ref : 44 ref

CODEN
JOHEEC
ISSN
0168-8278
Domaine scientifique
Gastroenterology
Editeur
Elsevier, Kidlington
Pays de publication
United Kingdom
Type de document
Article
Langue
English
Mot clé auteur
Angiogenesis Apoptosis Combined therapy Growth inhibition HCC xenografts
Mot clé (fr)
Angiogenèse Antiangiogénique Anticancéreux Apoptose Carcinome hépatocellulaire Croissance Ectopie Gastroentérologie Homme Hétérogreffe Modèle Sorafénib Traitement associé Cancer Greffe Inhibiteur de la tyrosine kinase Inhibiteur enzyme Inhibiteur multikinase Pathologie de l'appareil digestif Pathologie du foie Tumeur maligne
Mot clé (en)
Angiogenesis Antiangiogenic agent Antineoplastic agent Apoptosis Hepatocellular carcinoma Growth Ectopia Gastroenterology Human Heterograft Models Sorafenib Combined treatment Cancer Graft Tyrosine kinase inhibitor Enzyme inhibitor Multikinase inhibitor Digestive diseases Hepatic disease Malignant tumor
Mot clé (es)
Angiogénesis Antiangiogenico Anticanceroso Apoptosis Carcinoma hepatocelular Crecimiento Ectopia Gastroenterología Hombre Heteroinjerto Modelo Sorafenib Tratamiento asociado Cáncer Injerto Inhibidor tyrosine kinase Inhibidor enzima inhibidor multicinasa Aparato digestivo patología Hígado patología Tumor maligno
Classification
Pascal
002 Sciences biologiques et medicales / 002B Sciences medicales / 002B13 Gastroenterologie. Foie. Pancreas. Abdomen / 002B13C Foie. Voies biliaires. Circulation portale. Pancréas exocrine / 002B13C01 Tumeurs

Discipline
Gastroenterology. Liver. Pancreas. Abdomen
Provenance
Inist-CNRS
Base de données
PASCAL
Identifiant INIST
22275367

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Accès au Document

Rechercher sur le web